Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.

about

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.

Item

http://www.wikidata.org/entity/Q47958039

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Placebo response and remission ...... herapy for ulcerative colitis.

@en

Placebo response and remission ...... herapy for ulcerative colitis.

@nl

type

Item

label

Placebo response and remission ...... herapy for ulcerative colitis.

@en

Placebo response and remission ...... herapy for ulcerative colitis.

@nl

prefLabel

Placebo response and remission ...... herapy for ulcerative colitis.

@en

Placebo response and remission ...... herapy for ulcerative colitis.

@nl

P1476

Placebo response and remission ...... herapy for ulcerative colitis.

@en

P2093

Andreas Koutsoumpas

http://www.w3.org/2001/XMLSchema#string

Claire E Parker

http://www.w3.org/2001/XMLSchema#string

Daniël R Hoekman

http://www.w3.org/2001/XMLSchema#string

Elizabeth Minas

http://www.w3.org/2001/XMLSchema#string

G Y Zou

http://www.w3.org/2001/XMLSchema#string

Geert D'Haens

http://www.w3.org/2001/XMLSchema#string

John K MacDonald

http://www.w3.org/2001/XMLSchema#string

Mahmoud H Mosli

http://www.w3.org/2001/XMLSchema#string

Majid A Almadi

http://www.w3.org/2001/XMLSchema#string

Mark A Glaire

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Quantifying heterogeneity in a meta-analysis

How should meta-regression analyses be undertaken and interpreted?

Infliximab for induction and maintenance therapy for ulcerative colitis

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.

Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data.

First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses

Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.

P304

CD011572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/14651858.CD011572.PUB2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sujata Biswas

William Jeffery Sandborn

Brian G. Feagan

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28886205

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

6483671

http://www.w3.org/2001/XMLSchema#string